Alkermes

About

Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience. Focused on serious psychiatric and neurological disorders, our aim is to improve outcomes for patients, families, and communities through dedicated commitment to science and compassion. Our corporate ethos is defined by collaboration and respect for every individual. Through our culture of excellence, we promote diversity, inclusion, and belonging in all business aspects, striving to create an environment where every voice is heard. Alkermes recognizes that our commitment extends beyond our workforce to include collaboration with diverse suppliers and ensuring equitable representation in clinical trials. We work hand-in-hand with leading pharmaceutical companies and research institutions to tackle complex medical challenges, and we remain at the forefront of developing innovative treatments in the realm of mental health and addiction.